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Abstract
Signal transduction pathways activated by Toll-like Receptors and the IL-1 family of cytokines are fundamental to mounting
an innate immune response and thus to clearing pathogens and promoting wound healing. Whilst mechanistic
understanding of the regulation of innate signalling pathways has advanced considerably in recent years, there are still a
number of critical controllers to be discovered. In order to characterise novel regulators of macrophage inflammation, we
have carried out an extensive, cDNA-based forward genetic screen and identified 34 novel activators, based on their ability
to induce the expression of cxcl2. Many are physiologically expressed in macrophages, although the majority of genes
uncovered in our screen have not previously been linked to innate immunity. We show that expression of particular
activators has profound but distinct impacts on LPS-induced inflammatory gene expression, including switch-type, amplifier
and sensitiser behaviours. Furthermore, the novel genes identified here interact with the canonical inflammatory signalling
network via specific mechanisms, as demonstrated by the use of dominant negative forms of IL1/TLR signalling mediators.
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Introduction
It is widely believed that a significant fraction of mammalian
genes is involved in mediating resistance to pathogens [1]. Many of
these form part of innate signalling systems, a comprehensive
understanding of which remains elusive despite intense study,
partly because many components are still to be characterised.
Cataloguing the components of these signalling processes and their
interactions is a key goal of systems biology research [2].
Moreover, many of the presently unrecognised components may
become targets for future drug development in the context of
inflammatory disease.
Historically, several strategies have been employed to identify
such components, ranging from expression cloning of cytokines
and their receptors [3], genetic studies using mutant cells with
impaired ability to respond to inflammatory stimuli [4], protein-
protein interaction screens [5], homology-based identification [6],
and computational analysis of emerging genomic datasets [7].
These efforts have led to the development of the current model
of inflammatory signalling, whereby members of the IL-1R/TLR
family activate signalling via a group of adaptor proteins, MyD88,
Mal/TIRAP, TRIF and TRAM [8]. Upon receptor-ligand
interactions, further proteins are recruited to these multi-protein
complexes, including members of the IRAK kinase family [9].
This then leads to activation of TRAF6 ubiquitin ligase, which
interacts with TAK1 and TAB proteins and thus activates
downstream signal processing pathways, including the IkB/NFkB
complex and MAPK networks [10,11]. In addition to these,
distinct TLR receptors are able to induce cellular responses via
activating members of the IRF transcription factor family, namely
IRF3 and IRF7, in order to drive expression of type I interferons
(ifn) [8]. For this, the serine/threonine kinase TBK1 is essential for
phosphorylation and hence activation of IRF3 and IRF7 [12].
TBK1 is also critical for signalling by non-TLR intracellular
pathogen signalling systems, including DNA sensing systems [13–
15].
It is however clear that many components of innate signalling
pathways remain to be identified, most notably those which
control specificity and the amplitude of action or the previously
unrecognised genes interacting with the canonical signalling
network via novel mechanisms [1]. In recent years, we have
developed a screening platform that takes advantage of transcrip-
tional reporters inducible by inflammatory stimuli. We have
demonstrated the utility of this system by identifying previously
unknown proteins, the overexpression of which regulates the
activity of these reporters. Examples of these include the family of
tribbles proteins, the biology of which we have characterised [16–
18], miR155/BIC [19,20], and Jmj/JARID [21,22]. This
platform has also been adopted by others and has been used
successfully to identify a large number of novel signalling
regulators, with the aim of developing these as drug targets [23].
Similar approaches led to the recent identification of ERIS/
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STING and RIG-1 as novel regulators of interferon activation
[24,25].
Here we report the screening of a cDNA collection of 30,000
fully characterised murine expression clones, representing over
12,000 unique genes in Raw 264.7 macrophage-like cells, and the
identification of 34 mostly uncharacterised proteins which activate
the expression of a canonical target of pro-inflammatory signalling
systems, the cxcl2 (MIP-2) chemokine.
Results
Generation of a fully characterised, genome-wide mouse
cDNA collection
Library construction and sequencing. Three cDNA
libraries were created from mouse embryo, brain and spleen.
50,000 clones were picked from each of the three libraries, and
plasmid DNA from each was sequenced from the 59 end (see File
S1). Later in the process, selected clones were also sequenced from
the 39 end (see File S2).
A total of 140,000 59 sequence reads were obtained and
analysed: 118,490 sequences passed QC using Phred; following
vector clipping, .50 bp high quality sequence remained in 98,918
sequences which were mapped to the mouse genome using Blat.
Of these sequences, blat hits were found for 93,009 sequences
(94%), which were clustered into 13,909 clusters. The reasons for
the absence of hits in the other 6% are probably that they
represent highly repetitive sequence. The alignment revealed that
sequenced clones corresponded to 7,041 genes on the sense strand
and matching at least 2,900 genes on the antisense strand;
including 758 sequences matching genes on both the sense and
antisense strands. 8% of the 98,918 sequences did not match a
known gene or gene model. The three libraries were re-arrayed
into one non-redundant library and supplemented with 10,000
cDNA clones in the same expression vector from the IRAV part of
the mammalian Gene Collection (Source Biosciences, File S4).
The resulting non-redundant library contains 13,239 unique
reference sequences, ,45% of canonical mouse genes (http://
www.informatics.jax.org/genes.shtml) and the total number of
clones is approx. 30,000 (see File S5). Consequently, a number of
genes are represented by several splice variants and/or non-
protein coding mRNA species with putative regulatory function.
In order to simplify further referencing of our results obtained by
testing this cDNA collection, we named it the Mouse Transcrip-
tome Collection (MTC).
Identification of 34 activators of cxcl2 expression in Raw
264.7 cells
For high throughput screening of MTC (outlined in figure 1A),
plasmid preparation was performed for each clone and aliquots of
these were pooled into pools of 12 which were subsequently
transfected into Raw 264.7 cells, in triplicate (Figure 1B). Analysis
of variance (ANOVA) was used to identify pools that were able to
significantly enhance cxcl2 reporter activity above the background.
Clones from positive pools were tested individually and the cDNA
clone activating the cxcl2 reporter was identified (Figure 1C). 61
positive clones identified in the initial screen (Table 1) were
subsequently re-tested in further, independent transfections using
DNA purified using methods designed to minimise endotoxin
contamination (Figure 2A and highlighted in Table 1). 34 genes
induced cxcl2 activation reproducibly and statistically significantly
by at least two-fold, which is close to the detection limit in this
system.
Initial computational analysis revealed that the hits include
predicted secreted, transmembrane, intracellular and nuclear
proteins (Table 1). As shown in Table 2, genes with common
biological action (ion channels, transcription factors) and compo-
nents of common biological pathways (matrix modifiers, phos-
pholipid homeostasis) have been identified by the screen,
suggesting an important regulatory function for genes with such
activity in controlling macrophage inflammation. Further, using
publically available expression profile data at the BioGPS portal,
we showed that the majority of the proteins identified in the screen
are endogenously expressed in macrophages (Table 1). Interest-
ingly, analysis of transcripts for the hits revealed that 10 of these
contained cDNAs encoding only partial open reading frames
(Table 1), leading to the expression of truncated proteins. This
observation is in line with our previous findings, demonstrating
that ‘‘full-lengthness’’ is not a necessary requirement for the
detection of molecules with inflammation modulatory action [26].
Characterisation of the biological activity and specificity
of selected hits and their connections with inflammatory
pathways
Following the isolation of the 34 genes described above, further
transient transfection experiments were performed to characterise
their bioactivity using two additional transcriptional reporters,
driven by the promoters of the lipocalin 2 (lcn2) and the interferon
beta (ifnb) genes. These promoters were chosen by analysing
microarrays of stimulated Raw 264.7 cells and identifying genes
that were activated by proinflammatory stimuli but with distinct
kinetics. Details of our analysis and target selection for these assays
have previously been described [27]. We included 8, well
characterised pro-inflammatory signalling molecules (MAVS,
Traf3IP2/Ciks/Act1, Myd88, Tak1, Tram, Map3k11, Traf6,
and RIGI/T7) in these assays. Most of the 34 genes found were
weak ifnb inducers in Raw 264.7 cells (Figure 2A and B), with the
exception of MAP3K3, which induced levels of ifnb comparable
with the canonical ifnb inducers RIG-I (stimulated by T7-produced
transcripts) or MAVS. In contrast, activation of the lcn2 promoter
correlated well with that of the cxcl2 promoter, although genes that
preferentially induced one, but not the other were also observed,
including MyD88, Traf3IP2 and Prkaca (Figure 2A and C).
A range of modulators of signalling induced by TLR and
proinflammatory cytokine receptors have been uncovered during
the past decade and a number of variants of these genes have
recently been identified as risk factors for inflammatory disease
[28,29]. Therefore, we have investigated how elevated levels of 13
transcripts identified in the Raw 264.7 cell screen above would
affect LPS induced cxcl2 transcription. The genes analysed here
were selected to include molecules with a range of predicted
intracellular localisations (transmembrane proteins, intracellular
signalling molecules and transcription factors). Three well-
characterised mediators of inflammatory signalling were used as
positive controls (TRAF6, TAK1 and TRAM). Raw 264.7 cells
transfected with empty vector or a proinflammatory mediator
were stimulated by increasing doses of LPS for 6 hrs and the
activity of the cxcl2 promoter was measured (Figure 2D–F). All the
known proinflammatory signalling molecules tested, as well as
43% (6 of 14) of the novel proteins identified in our screen induced
maximal induction of cxcl2 in the absence of LPS (Fig. 2D and 2G,
‘‘switch’’ type response). In contrast, the remaining molecules
exhibited a different relationship with the LPS-induced reporter
responses: overexpression of 43% (6 of 14) of genes tested
amplified LPS-induced reporter activation, increasing the maxi-
mal response (Fig. 2E and G, ‘‘amplifier’’ response); the remaining
2 of 14 led to a reproducible and highly statistically significant shift
in the EC50 of the LPS induced dose-response, suggesting that
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these proteins are able to sensitise the cells to LPS (Fig. 2F and G,
‘‘sensitiser’’ response).
Thus, genes with diverse modes of action were identified in the
Raw 264.7 cell screen. However, the majority of these genes and
their protein products are not known to be involved in
inflammatory signal processing, and for a number of them there
is no published literature at all. Therefore, we characterised the
molecular mechanisms by which selected novel mediators interact
with the canonical inflammatory signalling machinery. Induction
of the cxcl2 reporter was monitored on co-transfection of
combinations of one dominant negative (DN), inhibitory molecule,
and one library hit. LPS was used as a positive control. Six novel
pro-inflammatory genes (a poorly characterised protein kinase
Mltk/ZAK; ion channels Kcnk3 and Kcnk12; a sulfotransferase
UST; a regulator of histone acetylation Suds3, and the transcrip-
tion factor Bcl11b) were tested in these experiments. The genes
were chosen on the basis of novelty to macrophage inflammation,
their diverse putative mode of action as well as their potency in
activating cxcl2 expression in our reporter assay.
As shown in Figure 3, the DN mutant proteins, which block the
TLR induced inflammatory signal transduction pathway at
specific points, included TIRAP, MyD88, TRAM, TRIF, TRAF6,
IRAK1 and Ras, respectively. As expected, LPS induced cxcl2
expression was inhibited by the various DN expression constructs
previously reported to affect TLR-mediated inflammatory signals
[30–35] (Fig. 3A), with the exception of Ras, the action of which is
dependent on extracellular matrix-cell interactions [36]. The novel
genes, however, generated distinct signals in this assay. For
example, the ability of Mltk to drive cxcl2 induction was
significantly inhibited by DN-IRAK1, -TRIF and -TRAF6,
indicating that Mltk is likely to act at the level of the receptor
complex, at the membrane (Figure 3A). A similar pattern of
inhibition was observed when UST induced cxcl2 expression was
inhibited by the DN constructs. In contrast, Kcnk3 -driven cxcl2
expression was only inhibited by DN-TRIF. Whilst these results
suggest that groups of novel signalling intermediates identified in
the screen may act via distinct but specific mechanisms, detailed
understanding of the molecular basis of these functional interac-
tions will require further investigation. A separate characterisation
of the likely physiological role of three hits (TMEM203, E4F1 and
MAP3K3) that are endogenously expressed in Raw 264.7 cells on
TLR agonist induced activation of cxcl2 expression is shown in
Fig. 4. siRNA mediated knockdown of TMEM203 and E4F1
expression led to impaired cxcl2 expression in response to LPS,
whereas knockdown of MAP3K3 expression had no significant
impact in this system (Fig. 4A). In contrast, induction of cxcl2
expression by the TLR7/8 agonist CL075 was not impaired by
knockdown of any of the genes tested (Fig. 4B), suggesting that the
Figure 1. Flow chart of the functional screen. A) shows the workflow of the screen. B) shows an example of the analysis performed on a plate
comprising 96 pools of 12. The hypothesis that individuals pools differ from the plate mean is tested using a linear model. Three pools (P1, P2, P3)
give signal over the 2logp.4 cut off used. Breakdown of pool P2 is shown in C) one constituent clone (#8) gives high-level induction. Dots
represent results of four independent replicates, performed for each clone.
doi:10.1371/journal.pone.0042388.g001
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proinflammatory mediators isolated in this screen may have a
distinct function in controlling signalling pathways that are
induced by specific TLRs.
Discussion
In the study described here, we have undertaken a cellular
screen for novel proinflammatory genes, detecting inducers of the
chemokine gene, cxcl2/in the macrophage-like cell line Raw 264.7.
The screen was extensive, and relied on both a low redundancy
cDNA library and our previously developed screening platform
[26,27,37–39].
We discovered at least 34 genes which induced the cxcl2
reporter, most of which were not previously known to be involved
in proinflammatory signalling. As discussed below, independent
biochemical experiments support a physiological role for many of
these genes. The high yield of previously unknown signalling
molecules from the screen may be related to the cell line used for
screening (Raw 264.7), which is widely recognised to retain many
properties of primary macrophages. As such, its phenotype differs
markedly from the readily manipulated epithelial cell lines (HeLa,
HEK293, etc.) which have been used in previous transcriptome
screens for inflammatory molecules. We note that in silico analysis
of the cell-type specific expression profile of hits from the screen
showed that the majority of the genes recovered in this exercise are
endogenously expressed in macrophages.
Among the 34 genes found, there are differences in their ability
to activate other, inflammation sensitive reporters, and they also
have a differential influence on LPS induced cxcl2 activation (see
Fig. 2). Some exhibit ‘‘switch on’’ like behaviour: on molecule
overexpression, the cell produces chemokines with limited impact
of additional endogenous stimuli. Others exhibit ‘‘amplifier’’
behaviour, shifting the LPS dose-response upwards. Genes in the
third category, ‘‘sensitisers’’ shift the LPS induced maximal cxcl2
activity leftward. We suggest that these latter two groups of genes
may be of significant physiological importance in the development
and maintenance of inflammatory disease. Additional support for
a physiological role for some of the genes found in this screen in
inflammatory signalling in macrophages comes from siRNA
studies in which 2 out of the three novel molecules tested impaired
LPS-induced signalling.
Genetic variants leading to an increase in the expression of such
genes would be postulated to lead to a hyper-responsive,
inflammatory phenotype, thus contributing to the susceptibility
to diseases with a significant inflammatory component. We have
recently reported the existence of such a phenotype in peripros-
thetic osteolysis, a condition that is driven by inflammatory
macrophages [40]. Whilst the molecular basis of this hyper-
inflammatory phenotype in osteolytic individuals is unclear,
genetic variants of genes reported in here may significantly
contribute to the development of this condition.
In addition to distinct influences on LPS mediated cxcl2
activation, experiments outlined in Figure 3 investigated the
molecular pathways by which a subset of our hits and the
canonical TLR signalling pathway interact. Although a wide range
of dominant negative molecules severely attenuated LPS signal-
ling, inhibition profiles for hits differed markedly. This emphasises
that, as reported by recent proteomic studies uncovering many
novel proteins mediating TNF signalling [5], many aspects of
macrophage inflammation remain poorly understood.
Whilst a number of genes identified in this study have the
characteristics of ‘‘canonical’’ signalling mediators and their
effectors, including MAP kinases and several transcription factors,
it is clear that many of the novel hits may highlight the importance
of additional regulatory mechanisms of inflammatory gene
expression. For instance, two members of the tandem pore K+
channel family (Kcnk3 and Kcnk12) have been identified in our
screen. Whilst these proteins have previously been studied in
neuronal cardiovascular systems [41], their roles in macrophages
have not previously been implicated. However, the importance of
intracellular potassium concentration in the activation of NAPL3
inflammasomes have been recently reported [42], thus providing a
potential mechanistic explanation for the action of Kcnk channels
in the control of cxcl2 expression.
Interactions between cells and the extracellular matrix have
been intensely studied and the importance of this in the control of
inflammatory processes is widely recognised. Adhesion molecules,
which are critical for the homing of inflammatory cells [43], as
well as in their activation, are modified by several groups of
enzymes, including sulfotransferases. These proteins have been
proposed as therapeutic targets in inflammation [44]. A recent
study have demonstrated a distinct expression profile for glyco-
and sulfotransferases in monocytes and macrophages, suggesting
that specific members of this enzyme superfamily may play a
distinct role in the function of monocytes and/or macrophages
[45]. Identification of UST, a poorly characterised sulfotransferase
fits this general theme whilst also highlighting the power of
functional screens to identify novel and specific members of
particular gene families.
High throughput approaches are increasingly being used to
discover genes involved in the control of mammalian innate
immunity. Such strategies include human genome wide associa-
tion studies (GWAS) of large cohorts with an inflammatory
disease, candidate based genetic validation studies, biochemical
complementation strategies [1,4], studies of protein complexes [5],
RNAi approaches [7,46], or overexpression based screens
identifying physiologically relevant signalling intermediates
[18,23,26,46–49]. These approaches complement each other,
with one approach identifying candidates whose physiological role
is further defined and validated by multiple other approaches. The
increase in systems biological resources, together with reagents for
loss of function screens including banks of mutant mice (e.g. the
KOMP consortium), will aid the rapid investigation of mecha-
nisms of the candidate macrophage inflammatory components
discovered here.
Figure 2. Activation of proinflammatory promoters by library hits and their impact on LPS induced cxcl2 activation in Raw 264.7
cells. Induction of three proinflammatory promoters (ifnb, cxcl2 and Lcn2) by plasmids recovered from the library screen and positive controls are
shown. Results are derived from 2 (for ifnb and lcn2) and between 3 and 13 independent experiments (for cxcl2), all performed in triplicate in each
experiment. A) Results are expressed as log fold increase of normalised promoter activity over background and 95% confidence intervals. B) and C)
show bivariate plots illustrating activity of the various molecules on the cxcl2, lcn2 and ifnb reporters. Effect estimates for molecules derived from the
screen are marked as circles, and known components of signalling system as triangles. D–F) Raw 264.7 cells were transfected with the cxcl2-pLuc and
EF1-rLuc reporters, as described in the methods, as well as with 60 ng/well expression plasmid, encoding known (TRAF6) (D) or novel
proinflammatory molecules (E and F). The impact of over-expressed proinflammatory mediators on LPS induced cxcl2 expression was tested. The
activity profile of the cDNAs tested were classified according to three distinct patterns, as exemplified in D–F and shown in G). Genes highlighted in
bold encode known components of inflammatory signal transduction (controls).
doi:10.1371/journal.pone.0042388.g002
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Table 1. Genes activating cxcl2-pLuc expression in Raw 264.7 cells.
Murine gene ID Human gene ID Gene name Predicted localisation
Expression in
macrophages Clone length
210741 56660 Kcnk12 Plasma membrane (P) N del
16527 3777 Kcnk3 Plasma membrane (E) C del
18830 5360 Pltp Secreted (E) +++
338362 10090 Ust Golgi, type II transmembrane protein (P) ++
73940 60484 Hapln2 Secreted C del
23934 4062 Ly6h Plasma membrane (E)
118454 57165 Gjc2/Gja12 Plasma membrane +
72114 84327 Zbed3 Intracellular +
20669 8403 Sox14 Nucleus (P) +
16319 3619 Incenp Nucleus (P) ++
72961 57030 Slc17a7 Plasma membrane
16478 3727 Jund1 Nucleus (E) +
234023 55082 Arglu1 Nucleus (P)
14809 2901 Grik5 Cytoplasmic vesicles (E) N del
631309 57719 TMEM16H/ANO8 Plasma membrane (P) + N del
15166 610 Hcn2 Plasma membrane (P) + N del
21869 7080 Titf1/NKX2-1 Nuclear (E) + N del
216157 91304 ORF61/membralin Plasma membrane (P) ++
Murine gene ID Human gene ID Gene name Predicted localisation
Expression in
macrophages Clone length
353156 51162 Egfl7 Secreted (P)
13116 10858 Cyp46a1 Secreted (P)
71954 64426 Suds3 Nuclear (E) +
231014 222223 9330182L06Rik/
KIAA1324L
Unknown +
21885 7088 Tle1 Nucleus (P)
12153 649 Bmp1 Secreted (E) C del
631901 6658 LOC631901 Unknown
58208 64919 Bcl11b Nucleus (P) N del
26561 8510 Mmp23 Extracellular (P)
64406 389058 Sp5 Nuclear (E)
67674 51504 Trmt112 Unknown +
13984 80712 Esx1 Nucleus (P) +
102566 55129 Tmem16k/ANO10 Plasma membrane (P) ++
22282 7392 Usf2 Nucleus (E) +++ N del
74123 116113 Foxp4 Nucleus (P) +
13560 1877 E4f1 Nucleus (E) +
53381 10549 Prdx4 Cytoplasm (E) ++
18747 5566 Prkaca Cytoplasm (P) ++
19217 5732 Ptger2 Plasma membrane (P) +++
14161 2243 Fga Secreted (E)
21423 6929 Tcfe2a/TCF3 Nucleus (E) +
23872 2114 Ets2 Nucleus (E) +++
Murine gene ID Human gene ID Gene name Predicted localisation
Expression in
macrophages Clone length
75965 253832 Zdhhc20 Plasma membrane (P)
20702 5265 Serpina1c Secreted (E)
17173 430 Ascl2 Nucleus (E) +
66350 81579 Pla2g12a ER (E) ++
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Materials and Methods
Library construction
cDNA from murine (Balb/c strain) brain and embryo was
purchased from Invitrogen (Carlsbad, CA). Splenocytes were
isolated from healthy 4–6 week old Balb/c mice. Four cultures of
109 splenocytes were established in RPMI 1640 containing 10%
fetal bovine serum. These were stimulated with either 10 mg/ml
LPS (E. coli O55:B5 derived, Sigma) or with 1 mg/ml Con-
canvalin A (Sigma) for 4 or 12 hours. RNA was extracted using
Qiagen RNEasy kits and the four samples pooled. Library
construction was subcontracted to Invitrogen (Carlsbad, CA).
Table 1. Cont.
Murine gene ID Human gene ID Gene name Predicted localisation
Expression in
macrophages Clone length
380794 Ighg Secreted (P)
227615 94107 Tmem203 Multipass transmembrane (P) ++
26406 4215 Map3k3 Cytoplasm (E) +++
13649 1956 Egfr Plasmamembrane (E)
240913 9507 Adamts4 Secreted (E)
65964 51776 B230120H23Rik/
Mltk/ZAK
Cytoplasm, nucleus (E)
67216 129642 Mboat2 Multipass membrane, ER (P)
76905 116844 Lrg1 Nucleus (E)
66950 55248 2310028N02Rik/
TMEM206
Cytoplasm, nucleus (P) +++
237553 29953 Trhde Membrane (P)
83383 7023 Tcfap4/TFAP4 Nucleus (E) +
21750 7014 Terf2 Nucleus (E)
78755 159090 Fam122b Nucleus (P)
14531 8521 Gcm1 Nucleus (P) +
97114 8352 Hist2h3c2 Nucleus (E) ++
246316 55203 Lgi2 Secreted (P)
102954 170685 Nudt10 Nucleus (P) +
Murine gene ID Human gene ID Gene name Predicted localisation
Expression in
macrophages Clone length
57890 132014 IL17re Membrane (E)
20664 6656 Sox1 Nucleus (E)
Genes encoding the mouse clones uncovered in the functional screen were identified in GenBank. Putative localisation of the various proteins have been assessed using
LOCATE (http://locate.imb.uq.edu.au/). Predicted localisation is indicated by (P), and experimentally verified cellular localisation is indicated by (E). Endogenous mouse
macrophage expression of the genes identified here has been characterised using BioGPS (http://biogps.gnf.org/). The relative abundance of macrophage expression,
compared to other cell types have been indicated (‘‘+++’’ is for high expression levels, ‘‘+’’ is for modest expression). Genes that induced cxcl2 expression in the absence
of residual Pathogen-associated molecular patterns (PAMP) contamination are highlighted in bold. Genes in bold induced the cxcl2 reporter .2 fold under strictly
endotoxin-free conditions.
C del denotes a C-terminal deletion in the library clone relative to the reference protein; N del denotes a N-terminal deletion in the library clone relative to the reference
protein.
doi:10.1371/journal.pone.0042388.t001
Table 2. Functionally linked groups of proteins uncovered in the screen.
Ion channels Transcriptional regulators
Modifiers of Extracellular
Matrix Signalling molecules Phospholipid homeostasis
Kcnk12, Kcnk3
Gjc2, Slc17a7
Hcn2,
ANO8, ANO10
Sox14, Incenp
JunD1, Titf1
Suds3, Tle1
Bcl11b, Sp5
Esx1, Usf2
Foxp4, E4F1
Ets2, Ascl2
Tcfap4, Terf2,
Sox1
Ust, Halpn
Mmp23, ADAMTS4
Prkaca, MAP3K3
ZAK, Lrg1
Pltp
Pla2g12a
Mboat2
Groups of proteins sharing similar biological function and modifiers of common processes identified as cxcl2 activators in the functional screen.
doi:10.1371/journal.pone.0042388.t002
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Figure 4. Selected screen hits are required for TLR4 but not for TLR7/8 induced cxcl2 induction. Raw 264.7 cells were transfected with
the cxcl2-pLuc and EF1-rLuc reporters, as described in the methods, as well as with 10 pmol siRNA (ON-TARGET plus SMART pool, Dharmacon) aginst
selected hits that are endogenously expressed in these cells. The impact of siRNA knockdown on A) LPS (20 ng/ml) or B) CL075 (2 mg/ml) induced
cxcl2 reporter activation was measured after 6 hrs stimulation. White bars: vehicle, grey bars: agonist added. Data was analysed by two-way ANOVA
modelling effect of agonist (LPS or CL075) and siRNA (four categories). Significance was determined from contrast estimates from the model
(***p,0.001, ****p,0.0001). A representative experiment of three, with similar results, is shown.
doi:10.1371/journal.pone.0042388.g004
Figure 3. Screen hits interact with the canonical proinflammatory signalling network via distinct molecular mechanisms. A) Raw
264.7 cells were transfected with the cxcl2-pLuc and EF1-rLuc reporters, as described in the methods, as well as with 30 ng/well expression plasmid,
encoding for dominant negative (DN) mutants of known proinflammatory molecules (MyD88, TRAM, TIRAP, TRIF, IRAK1, TRAF6 and Ras, respectively).
LPS (100 ng/ml) was used as a positive control (6 hrs stimulation) to test for the inhibitory activity of the DN constructs used. Data are derived from
three independent experiments, as described in Methods. *p,0.05 , **p,0.01, ***p,0.001 B) summarises the interactions observed in A.
doi:10.1371/journal.pone.0042388.g003
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Reverse transcription was performed using a Not I-poly T primer.
After second strand synthesis, cDNA was blunted, digested with
Not I, and ligated into the pCMV-SPORT6 mammalian
expression vector (Invitrogen), which was opened with EcoR V
and Not I. Sequencing was done by Agencourt Biosciences (now
part of Beckman Coulter) using ABI 3700 machines. The SP6
primer (which lies between the CMV promoter and 59 end of the
polylinker) was used for the 59 end sequencing and the T7 (reverse)
primer was used for the 39 end.
Bioinformatic processing
Base calls were performed with Phred [50], trace and vector
clipping with Lucy [51], and low complexity regions detected and
masked using RepeatMasker (http://www.repeatmasker.org).
Traces were mapped to the mouse mm36 NCBI reference
sequence (April 2006), chromosome by chromosome, using Blat
[52]; all mouse reference sequences and experimental gene models
were downloaded 1 February 2007 from NCBI. The position and
strand to which the most 59 portion of each read matched the
mouse genome was determined, and 59 ends were clustered using
the QTClust [53] algorithm with radius 250, as implemented in
the R flexclust package (see File S3). Clones from each cluster were
selected based on the alignment pattern to the genome, such that
different isoforms would be represented in the library.
Plasmids
Expression vectors. A range of open reading frames
encoding known components of pro-inflammatory signalling
systems, without untranslated regions, were inserted into a version
of pCMV-SPORT6 mammalian expression vector, whose poly-
linker was modified by linker ligation. Clones were obtained either
by PCR from murine cDNA libraries, or by subcloning from
vectors purchased from Invivogen.
Reporter vectors. Reporter vectors used include pGL4.cxcl2
and pGL4.ifnb, which contain the mouse cxcl2 and ifnb promoters
in pGL4 (Promega) and have been previously described [27].
pGL4.lcn2 contains a 234 to +1404 fragment from murine lcn2
promoter, subcloned from a reporter vector kindly provided by Dr
S Gaffen [54]. As an internal control, pGL4.EF1.rLuc was used;
this was constructed by PCR amplification of the human EF1
promoter from pEF-BOS [55] and insertion of the promoter into
pGL4 at the Nhe I site.
All vectors were confirmed by sequencing.
Cell lines and transient transfections. Raw 264.7 cells
were purchased from ATCC (Cat. No: TIB-71) and maintained
according to the suppliers’ recommendations. All transfections
described in this study were performed in 96 well plates. For the
cDNA screen, DNA was prepared using the Wizard 96 SV
(Promega) system and jetPEI (Polyplus) based transfection was
used, as recommended by the manufacturer (250 ng/well plasmid
DNA (including 125 ng reporter DNA and 25 ng cDNA
expression plasmid/well) and 0.5 ml/well jetPEI). For the
‘‘secondary activity screen’’ all plasmids were purified with
EndoFree maxiprep kits (Qiagen). 60 ng of empty pCS6 plasmid,
or insert containing plasmid, was mixed with 115 ng of reporter
plasmid (either pGL4, pGL4.cxcl2, pGL4.ifnb, or pGL4.lcn2) and
5 ng of control plasmid pGL4.EF1.rLuc. Transfections were
performed with Superfect (Qiagen) 2.5 ml/well, according to the
manufacturer’s protocol. After transfection, cells were incubated in
100 ml of complete medium (DMEM+10% heat inactivated fetal
bovine serum). In some cases, 16 hours after transfection, agonists
(typically LPS, E. coli O55:B5, Sigma) were added in 5 ml of PBS
to the medium. Cells were lysed 24 hours after stimulation and
luciferase assays performed with Dual Luciferase Assay Kits
(Promega).
Subsequent transfections for validation and characterisation of
the hits were carried out under similar conditions.
Statistical analysis and identification of hits in the high
throughput screen
Gene expression data were normalised, that is expressed as
Photinus luciferase activity (cxcl2) relative to the constitutive Renilla
luciferase activity (EF1) within each well. Preliminary data analysis
suggested that the data were approximately log-normally distrib-
uted, so general linear modelling was used to estimate effects of
various conditions (including transfection) on log-transformed
normalised luciferase activity using Stata 11 and R 2.11 software.
Effect of inhibitory molecules on hit-induced activation
The DN molecules, used in this study have been described
previously [30–35]. Briefly, DN-TIRAP encoded a mutant where
proline-125 was substituted with histidine. DN-MyD88 expressed
a mutant version of MyD88 encoding the death domain (aa 1–
151). DN- TRIF encoded only for the TIR domain (aa387–566).
Furthermore, it contained a proline to histidine mutation at aa 434
that is essential for activation of the TLR-mediated signalling. DN-
TRAM expressed a cysteine to histidine mutant at aa 117.
IRAK1-DN expressed only the N-terminal domain of the protein
containing the death domain (aa 1–211). TRAF6-DN (aa 289–
522) expressed a mutant lacking the N-terminal domain of the
protein. DN-Ras encoded a mutant protein where serine 17 was
changed to aspargine.
30 ng of ‘‘hit’’ expression plasmid, 30 ng of DN protein
expression plasmid, 115 ng of reporter plasmid (pGL4.cxcl2) and
5 ng of control plasmid pGL4.EF1.rLuc were co-transfected into
Raw 264.7 cells, using Superfect (Qiagen), as described above.
Three independent experiments were carried out, all with similar
results. Log2 luciferase activity was modeled using the glm function
in the R software package as a function of inhibitor/activator
combination and the activator (since some activators produce
more stimulus than others) and experiment (as absolute luciferase
levels varied somewhat from experiment to experiment). Signifi-
cance of change was assessed using contrasts generated by the
model.
Effect of siRNA molecules on LPS and CL075-induced
cytokine activation
Raw 264.7 cells were transfected with the cxcl2-pLuc and EF1-
rLuc reporters, as described above, as well as with 10 pmol siRNA
(ON-TARGET plus SMART pool, Dharmacon) aginst selected
hits that are endogenously expressed in these cells. The impact of
siRNA knockdown on LPS (20 ng/ml) or CL075 (2 mg/ml) [56]
induced cxcl2 reporter activation was measured after 6 hrs
stimulation. White bars: vehicle, grey bars: agonist added. Data
was analysed by two-way ANOVA modelling effect of agonist
(LPS or CL075) and siRNA (four categories). Significance was
determined from contrast estimates from the model.
Supporting Information
File S1 Forward Sequences of cDNA library. The
sequences of forward reads from the cDNA library are shown.
Sequences are clipped based on Phred quality scores.
(CSV)
File S2 Reverse Reads from cDNA library. The sequences
of reverse reads from the cDNA library are shown. Sequences are
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clipped based on Phred quality scores. No sequence is shown
where reverse sequencing did not pass quality control criteria.
(CSV)
File S3 Mapping of selected clones to the mouse
genome. Sequences of reads were mapped to the mouse mm36
reference genome using Blat. The positions of the 59 end of each
read were clustered to within 250-base pair groups. Positions of the
13,909 clusters generated are shown, mapped to the mm36 mouse
genome.
(GFF)
File S4 Sequences of clones from MGC collections.
Stated sequences of the clones from the MGC collection used to
supplement the library are shown.
(CSV)
File S5 Annotated list of library clones and contents.
Identities of clones obtained from the two-stage library construc-
tion process are shown.
(CSV)
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